Precision Biosciences (DTIL) Capital Expenditures Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | -71.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.88% |
| Dec 31, 2025 | -80.41% |
| Jun 30, 2025 | -92.86% |
| Mar 31, 2025 | -25.58% |
| Dec 31, 2024 | 473.08% |
| Sep 30, 2024 | -89.90% |
| Jun 30, 2024 | -97.40% |
| Mar 31, 2024 | -83.49% |
| Dec 31, 2023 | -104.11% |
| Sep 30, 2023 | -64.59% |
| Jun 30, 2023 | 38.13% |
| Mar 31, 2023 | -36.31% |
| Dec 31, 2022 | -58.01% |
| Sep 30, 2022 | 48.70% |
| Jun 30, 2022 | -53.91% |
| Mar 31, 2022 | -27.29% |
| Dec 31, 2021 | 37.32% |
| Sep 30, 2021 | -29.99% |
| Jun 30, 2021 | -5.32% |
| Mar 31, 2021 | 1.99% |